Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Zepbound Tops Wegovy for Weight Loss
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.
Which Weight-Loss Drug Is Better: Wegovy or Zepbound?
With more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more effective? In a press release, Lilly announced that in its latest trial comparing its medication,
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly.
STAT
5h
Pharmalittle: We’re reading about a Zepbound-Wegovy faceoff, compounders slamming Novo, and more
Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo ...
6h
New study compares weight loss drugs Wegovy and Zepbound
A new study is out that compares the effectiveness of two popular weight loss drugs, Wegovy and Zepbound. The study, which ...
BioPharma Dive
1d
Diabetes advocacy group discourages use of compounded GLP-1 drugs
The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that ...
6d
Dr. Roach: In two cases, Zepbound provides great benefit to overall health
Dear S.R.: Tirzepatide (Zepbound), like semaglutide, is a prescription medication originally used for diabetes but now ...
53m
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
A new study is shedding light on which of two drugs currently approved by the U.S. Food and Drug Administration for weight ...
1d
Weight-loss drugs deliver life-changing health benefits - and big profits
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
Opinion
1d
Opinion
A Thumb on the Scale for Wegovy
Biden’s Center for Medicare and Medicaid Services extends coverage by making nonsense of the law.
2d
Eli Lilly’s Growth Driven by Strong Prescription Trends for Mounjaro and Zepbound
Analyst Terence Flynn from Morgan Stanley maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and increased the price target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Wegovy
Eli Lilly
Novo Nordisk
Amgen
Glucagon-like peptide-1
Feedback